According to Arvinas's latest financial reports the company's current earnings (TTM) are -$0.41 B. In 2022 the company made an earning of -$0.26 B a decrease over its 2021 earnings that were of -$0.2 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.41 B | 57.08% |
2022 | -$0.26 B | 31.87% |
2021 | -$0.2 B | 62.52% |
2020 | -$0.12 B | 69.88% |
2019 | -$70.21 M | 69.49% |
2018 | -$41.43 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -72.41% | ๐บ๐ธ USA |